急性間欠性ポルフィリン症薬の世界市場動向・分析2018-2025

【英語タイトル】Global Acute Intermittent Porphyria Drugs Industry Research Report, Growth Trends and Competitive Analysis 2018-2025

QYResearchが出版した調査資料(QYR8D00084)・商品コード:QYR8D00084
・発行会社(調査会社):QYResearch
・発行日:2018年11月9日(※2024年版があります。お問い合わせください)
・ページ数:115
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル、世界主要国
・産業分野:製薬・ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートは、急性間欠性ポルフィリン症薬の世界市場について調査・分析し、種類別には、350mg、313mgに、用途別には、病院、薬局に区分してまとめました。調査対象企業は、Abbott等です。

・レポートの概要
・グローバル成長トレンド
・急性間欠性ポルフィリン症薬の世界市場規模
・急性間欠性ポルフィリン症薬の地域別市場規模
・グローバル産業動向
・企業別市場シェア
・企業別急性間欠性ポルフィリン症薬の価格動向
・急性間欠性ポルフィリン症薬の種類別市場規模(350mg、313mg)
・急性間欠性ポルフィリン症薬の用途別市場規模(病院、薬局)
・急性間欠性ポルフィリン症薬の北米市場(アメリカ、カナダ、メキシコ)
・急性間欠性ポルフィリン症薬のヨーロッパ市場(ドイツ、フランス、イギリス、イタリア、ロシア)
・急性間欠性ポルフィリン症薬のアジア市場(日本、中国、韓国、インド、オーストラリア、インドネシア、タイ、マレーシア、フィリピン、ベトナム)
・急性間欠性ポルフィリン症薬の中南米市場(ブラジル等)
・急性間欠性ポルフィリン症薬の中東・アフリカ市場(GCC、エジプト、南アフリカ)
・主要企業情報(Abbott)
 -企業概要、事業概要、販売・売上・市場シェア、XXX製品概要、企業動向
・バリューチェーン及び販売チャネル分析
・急性間欠性ポルフィリン症薬の市場規模予測
・急性間欠性ポルフィリン症薬の種類別市場予測2018-2025(350mg、313mg)
・急性間欠性ポルフィリン症薬の用途別市場予測2018-2025(病院、薬局)
・急性間欠性ポルフィリン症薬の北米市場予測2018-2025(アメリカ、カナダ、メキシコ)
・急性間欠性ポルフィリン症薬のヨーロッパ市場予測2018-2025(ドイツ、フランス、イギリス、イタリア、ロシア)
・急性間欠性ポルフィリン症薬のアジア市場予測2018-2025(日本、中国、韓国、インド、オーストラリア、インドネシア、タイ、マレーシア、フィリピン、ベトナム)
・急性間欠性ポルフィリン症薬の中南米市場予測2018-2025(ブラジル等)
・急性間欠性ポルフィリン症薬の中東・アフリカ市場予測2018-2025(GCC、エジプト、南アフリカ)
・調査結果及び結論
【レポートの概要】

Acute intermittent porphyria (AIP), also called Swedish porphyria, pyrroloporphyria, intermittent acute porphyria) is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It is the most common of the acute porphyrias.In 2018, the global Acute Intermittent Porphyria Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Acute Intermittent Porphyria Drugs.

This study researches the market size of Acute Intermittent Porphyria Drugs, presents the global Acute Intermittent Porphyria Drugs sales and revenue by companies, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.
This report focuses on the key data information of Acute Intermittent Porphyria Drugs in key regions like North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa, presents sales, revenue, market share, growth rate of Acute Intermittent Porphyria Drugs for each region and countries in each region.
For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2013 to 2018.
This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

This report includes the following manufacturers; we can also add the other companies as you want.
Abbott

Market Segment by Product Type
350mg
313mg

Market Segment by Application
Hospital
Pharmacy

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Egypt
South Africa

The study objectives are:
To analyze and research the global Acute Intermittent Porphyria Drugs status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Acute Intermittent Porphyria Drugs manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Acute Intermittent Porphyria Drugs are as follows:
History Year: 2013-2018
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Acute Intermittent Porphyria Drugs Market Size Growth Rate by Type
1.3.2 350mg
1.3.3 313mg
1.4 Market Segment by Application
1.4.1 Global Acute Intermittent Porphyria Drugs Market Share by Application (2018-2025)
1.4.2 Hospital
1.4.3 Pharmacy
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Acute Intermittent Porphyria Drugs Market Size
2.1.1 Global Acute Intermittent Porphyria Drugs Revenue 2013-2025
2.1.2 Global Acute Intermittent Porphyria Drugs Sales 2013-2025
2.2 Acute Intermittent Porphyria Drugs Growth Rate by Regions
2.2.1 Global Acute Intermittent Porphyria Drugs Sales by Regions 2013-2018
2.2.2 Global Acute Intermittent Porphyria Drugs Revenue by Regions 2013-2018
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Acute Intermittent Porphyria Drugs Sales by Manufacturers
3.1.1 Acute Intermittent Porphyria Drugs Sales by Manufacturers 2013-2018
3.1.2 Acute Intermittent Porphyria Drugs Sales Market Share by Manufacturers 2013-2018
3.2 Revenue by Manufacturers
3.2.1 Acute Intermittent Porphyria Drugs Revenue by Manufacturers (2013-2018)
3.2.2 Acute Intermittent Porphyria Drugs Revenue Share by Manufacturers (2013-2018)
3.2.3 Global Acute Intermittent Porphyria Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Acute Intermittent Porphyria Drugs Price by Manufacturers
3.4 Key Manufacturers Acute Intermittent Porphyria Drugs Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Acute Intermittent Porphyria Drugs Market
3.6 Key Manufacturers Acute Intermittent Porphyria Drugs Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 350mg Sales and Revenue (2013-2018)
4.1.2 313mg Sales and Revenue (2013-2018)
4.2 Global Acute Intermittent Porphyria Drugs Sales Market Share by Type
4.3 Global Acute Intermittent Porphyria Drugs Revenue Market Share by Type
4.4 Acute Intermittent Porphyria Drugs Price by Type

5 Market Size by Application
5.1 Overview
5.2 Global Acute Intermittent Porphyria Drugs Sales by Application

6 North America
6.1 North America Acute Intermittent Porphyria Drugs Breakdown Data by Company
6.2 North America Acute Intermittent Porphyria Drugs Breakdown Data by Type
6.3 North America Acute Intermittent Porphyria Drugs Breakdown Data by Application
6.4 North America Acute Intermittent Porphyria Drugs Breakdown Data by Countries
6.4.1 North America Acute Intermittent Porphyria Drugs Sales by Countries
6.4.2 North America Acute Intermittent Porphyria Drugs Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico

7 Europe
7.1 Europe Acute Intermittent Porphyria Drugs Breakdown Data by Company
7.2 Europe Acute Intermittent Porphyria Drugs Breakdown Data by Type
7.3 Europe Acute Intermittent Porphyria Drugs Breakdown Data by Application
7.4 Europe Acute Intermittent Porphyria Drugs Breakdown Data by Countries
7.4.1 Europe Acute Intermittent Porphyria Drugs Sales by Countries
7.4.2 Europe Acute Intermittent Porphyria Drugs Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Acute Intermittent Porphyria Drugs Breakdown Data by Company
8.2 Asia Pacific Acute Intermittent Porphyria Drugs Breakdown Data by Type
8.3 Asia Pacific Acute Intermittent Porphyria Drugs Breakdown Data by Application
8.4 Asia Pacific Acute Intermittent Porphyria Drugs Breakdown Data by Countries
8.4.1 Asia Pacific Acute Intermittent Porphyria Drugs Sales by Countries
8.4.2 Asia Pacific Acute Intermittent Porphyria Drugs Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 Korea
8.4.6 India
8.4.7 Australia
8.4.8 Indonesia
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Thailand
8.4.12 Vietnam

9 Central & South America
9.1 Central & South America Acute Intermittent Porphyria Drugs Breakdown Data by Company
9.2 Central & South America Acute Intermittent Porphyria Drugs Breakdown Data by Type
9.3 Central & South America Acute Intermittent Porphyria Drugs Breakdown Data by Application
9.4 Central & South America Acute Intermittent Porphyria Drugs Breakdown Data by Countries
9.4.1 Central & South America Acute Intermittent Porphyria Drugs Sales by Countries
9.4.2 Central & South America Acute Intermittent Porphyria Drugs Revenue by Countries
9.4.3 Brazil

10 Middle East and Africa
10.1 Middle East and Africa Acute Intermittent Porphyria Drugs Breakdown Data by Type
10.2 Middle East and Africa Acute Intermittent Porphyria Drugs Breakdown Data by Application
10.3 Middle East and Africa Acute Intermittent Porphyria Drugs Breakdown Data by Countries
10.3.1 Middle East and Africa Acute Intermittent Porphyria Drugs Sales by Countries
10.3.2 Middle East and Africa Acute Intermittent Porphyria Drugs Revenue by Countries
10.3.3 GCC Countries
10.3.4 Egypt
10.3.5 South Africa

11 Company Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of Acute Intermittent Porphyria Drugs
11.1.4 Acute Intermittent Porphyria Drugs Product Introduction
11.1.5 Abbott Recent Development

12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Acute Intermittent Porphyria Drugs Sales Channels
12.2.2 Acute Intermittent Porphyria Drugs Distributors
12.3 Acute Intermittent Porphyria Drugs Customers

13 Market Forecast
13.1 Global Acute Intermittent Porphyria Drugs Sales and Revenue Forecast 2018-2025
13.2 Global Acute Intermittent Porphyria Drugs Sales Forecast by Type
13.3 Global Acute Intermittent Porphyria Drugs Sales Forecast by Application
13.4 Acute Intermittent Porphyria Drugs Forecast by Regions
13.4.1 Global Acute Intermittent Porphyria Drugs Sales Forecast by Regions 2018-2025
13.4.2 Global Acute Intermittent Porphyria Drugs Revenue Forecast by Regions 2018-2025
13.5 North America Market Forecast
13.5.1 North America Acute Intermittent Porphyria Drugs Forecast by Countries 2018-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe Acute Intermittent Porphyria Drugs Forecast by Countries 2018-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific Acute Intermittent Porphyria Drugs Sales Forecast by Countries 2018-2025
13.7.2 China
13.7.3 Japan
13.7.4 Korea
13.7.5 India
13.7.6 Australia
13.7.7 Indonesia
13.7.8 Thailand
13.7.9 Malaysia
13.7.10 Philippines
13.7.11 Vietnam
13.8 Central & South America Market Forecast
13.8.1 Central & South America Acute Intermittent Porphyria Drugs Sales Forecast by Countries 2018-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa Acute Intermittent Porphyria Drugs Sales Forecast by Countries 2018-2025
13.9.2 GCC Countries
13.9.3 Egypt
13.9.4 South Africa

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Tables and Figures

Figure Acute Intermittent Porphyria Drugs Product Picture
Table Acute Intermittent Porphyria Drugs Key Market Segments
Table Major Manufacturers Acute Intermittent Porphyria Drugs Covered in This Report
Table Global Acute Intermittent Porphyria Drugs Market Size Growth Rate by Type 2018-2025 (K Units) & (Million US$)
Figure Global Acute Intermittent Porphyria Drugs Sales Market Shar by Type 2013-2025
Figure 350mg Figures
Table Major Manufacturers of 350mg
Figure 313mg Figures
Table Major Manufacturers of 313mg
Table Global Acute Intermittent Porphyria Drugs Market Share by Application 2018-2025 (K Units)
Figure Hospital Use Case
Figure Pharmacy Use Case
Figure Acute Intermittent Porphyria Drugs Report Years Considered
Figure Global Acute Intermittent Porphyria Drugs Market Size 2013-2025 (Million US$)
Figure Global Acute Intermittent Porphyria Drugs Sales 2013-2018 (K Units)
Table Global Acute Intermittent Porphyria Drugs Market Size by Regions 2013-2018 (K Units) & (Million US$)
Table Global Acute Intermittent Porphyria Drugs Sales by Regions 2013-2018 (K Units)
Table Global Acute Intermittent Porphyria Drugs Sales Market Share by Regions 2013-2018
Figure Global Acute Intermittent Porphyria Drugs Sales Market Share by Regions 2013-2018
Figure Global Acute Intermittent Porphyria Drugs Sales Market Share by Regions in 2018
Table Global Acute Intermittent Porphyria Drugs Revenue by Regions 2013-2018 (Million US$)
Table Global Acute Intermittent Porphyria Drugs Revenue Market Share by Regions 2013-2018
Figure Global Acute Intermittent Porphyria Drugs Revenue Market Share by Regions 2013-2018
Figure Global Acute Intermittent Porphyria Drugs Revenue Market Share by Regions in 2018
Table Market Top Trends
Table Global Acute Intermittent Porphyria Drugs Sales by Manufacturers (2013-2018) (K Units)
Table Global Acute Intermittent Porphyria Drugs Sales Share by Manufacturers (2013-2018)
Figure Global Acute Intermittent Porphyria Drugs Sales Share by Manufacturers in 2018
Table Acute Intermittent Porphyria Drugs Revenue by Manufacturers (2013-2018) (Million USD)
Table Acute Intermittent Porphyria Drugs Revenue Share by Manufacturers (2013-2018)
Figure Acute Intermittent Porphyria Drugs Value Share by Manufacturers in 2018
Table Global Acute Intermittent Porphyria Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Acute Intermittent Porphyria Drugs Price (2013-2018) (USD/Unit)
Table Key Manufacturers Acute Intermittent Porphyria Drugs Plants/Factories Distribution
Table Key Manufacturers Acute Intermittent Porphyria Drugs Area Served
Table Date of Key Manufacturers Enter into Acute Intermittent Porphyria Drugs Market
Table Key Manufacturers Acute Intermittent Porphyria Drugs Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global 350mg Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global 313mg Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global Acute Intermittent Porphyria Drugs Sales by Type (2013-2018) (K Units)
Table Global Acute Intermittent Porphyria Drugs Sales Share by Type (2013-2018)
Figure Global Acute Intermittent Porphyria Drugs Sales Market Share by Type (2013-2018)
Figure Global Acute Intermittent Porphyria Drugs Sales Market Share by Type in 2017
Table Global Acute Intermittent Porphyria Drugs Revenue by Type (2013-2018) (Million US$)
Table Global Acute Intermittent Porphyria Drugs Revenue Share by Type (2013-2018)
Figure Global Acute Intermittent Porphyria Drugs Revenue Market Share by Type (2013-2018)
Figure Global Acute Intermittent Porphyria Drugs Revenue Market Share by Type in 2017
Table Acute Intermittent Porphyria Drugs Price by Type 2013-2018 (USD/Unit)
Table Global Acute Intermittent Porphyria Drugs Sales by Application (2013-2018) (K Units)
Table Global Acute Intermittent Porphyria Drugs Sales Share by Application (2013-2018)
Figure Global Sales Acute Intermittent Porphyria Drugs Market Share by Application (2013-2018)
Figure Global Sales Acute Intermittent Porphyria Drugs Market Share by Application in 2017
Figure North America Acute Intermittent Porphyria Drugs Sales Growth Rate 2013-2018 (K Units)
Figure North America Acute Intermittent Porphyria Drugs Revenue Growth Rate 2013-2018 (Million US$)
Table North America Acute Intermittent Porphyria Drugs Sales by Company (2013-2018) (K Units)
Table North America Acute Intermittent Porphyria Drugs Sales Market Share by Company (2013-2018)
Figure North America Acute Intermittent Porphyria Drugs Sales Market Share by Company in 2018
Table North America Acute Intermittent Porphyria Drugs Sales by Type (2013-2018) (K Units)
Table North America Acute Intermittent Porphyria Drugs Sales Market Share by Type (2013-2018)
Figure North America Acute Intermittent Porphyria Drugs Market Share by Type in 2018
Table North America Acute Intermittent Porphyria Drugs Sales by Application (2013-2018) (K Units)
Table North America Acute Intermittent Porphyria Drugs Sales Market Share by Application (2013-2018)
Figure North America Acute Intermittent Porphyria Drugs Market Share by Application in 2018
Table North America Acute Intermittent Porphyria Drugs Sales by Countries (2013-2018) (K Units)
Table North America Acute Intermittent Porphyria Drugs Sales Market Share by Countries (2013-2018)
Figure 2017 North America Acute Intermittent Porphyria Drugs Sales Market Share by Countries
Table North America Acute Intermittent Porphyria Drugs Revenue by Countries (2013-2018) (Million US$)
Table North America Acute Intermittent Porphyria Drugs Revenue Market Share by Countries (2013-2018)
Figure 2017 North America Acute Intermittent Porphyria Drugs Revenue Market Share by Countries
Figure United States Acute Intermittent Porphyria Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Canada Acute Intermittent Porphyria Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Mexico Acute Intermittent Porphyria Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Europe Acute Intermittent Porphyria Drugs Sales Growth Rate 2013-2018 (K Units)
Figure Europe Acute Intermittent Porphyria Drugs Revenue Growth Rate 2013-2018 (Million US$)
Table Europe Acute Intermittent Porphyria Drugs Sales by Company (2013-2018) (K Units)
Table Europe Acute Intermittent Porphyria Drugs Sales Market Share by Company (2013-2018)
Figure Europe Acute Intermittent Porphyria Drugs Sales Market Share by Company in 2018
Table Europe Acute Intermittent Porphyria Drugs Sales by Type (2013-2018) (K Units)
Table Europe Acute Intermittent Porphyria Drugs Sales Market Share by Type (2013-2018)
Figure 2017 Europe Acute Intermittent Porphyria Drugs Market Share by Type
Table Europe Acute Intermittent Porphyria Drugs Sales by Application (2013-2018) (K Units)
Table Europe Acute Intermittent Porphyria Drugs Sales Market Share by Application (2013-2018)
Figure 2017 Europe Acute Intermittent Porphyria Drugs Market Share by Application
Table Europe Acute Intermittent Porphyria Drugs Sales by Countries (2013-2018) (K Units)
Table Europe Acute Intermittent Porphyria Drugs Sales Market Share by Countries (2013-2018)
Figure 2017 Europe Acute Intermittent Porphyria Drugs Sales Market Share by Countries
Table Europe Acute Intermittent Porphyria Drugs Revenue by Countries (2013-2018) (Million US$)
Table Europe Acute Intermittent Porphyria Drugs Revenue Market Share by Countries (2013-2018)
Figure Europe Acute Intermittent Porphyria Drugs Revenue Market Share by Countries in 2018
Figure Germany Acute Intermittent Porphyria Drugs Sales Growth Rate (2013-2018) (K Units)
Figure France Acute Intermittent Porphyria Drugs Sales Growth Rate (2013-2018) (K Units)
Figure UK Acute Intermittent Porphyria Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Italy Acute Intermittent Porphyria Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Russia Acute Intermittent Porphyria Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Asia Pacific Acute Intermittent Porphyria Drugs Sales Growth Rate 2013-2018 (K Units)
Figure Asia Pacific Acute Intermittent Porphyria Drugs Revenue Growth Rate 2013-2018 (Million US$)
Table Asia Pacific Acute Intermittent Porphyria Drugs Sales by Company (2013-2018) (K Units)
Table Asia Pacific Acute Intermittent Porphyria Drugs Sales Market Share by Company (2013-2018)
Figure Asia Pacific Acute Intermittent Porphyria Drugs Sales Market Share by Company in 2018
Table Asia Pacific Acute Intermittent Porphyria Drugs Sales by Type (2013-2018) (K Units)
Table Asia Pacific Acute Intermittent Porphyria Drugs Sales Market Share by Type (2013-2018)
Figure Asia Pacific Acute Intermittent Porphyria Drugs Market Share by Type in 2018
Table Asia Pacific Acute Intermittent Porphyria Drugs Sales by Application (2013-2018) (K Units)
Table Asia Pacific Acute Intermittent Porphyria Drugs Sales Market Share by Application (2013-2018)
Figure Asia Pacific Acute Intermittent Porphyria Drugs Market Share by Application in 2018
Table Asia Pacific Acute Intermittent Porphyria Drugs Sales by Countries (2013-2018) (K Units)
Table Asia Pacific Acute Intermittent Porphyria Drugs Sales Market Share by Countries (2013-2018)
Figure 2017 Asia Pacific Acute Intermittent Porphyria Drugs Sales Market Share by Countries
Table Asia Pacific Acute Intermittent Porphyria Drugs Revenue by Countries (2013-2018) (Million US$)
Table Asia Pacific Acute Intermittent Porphyria Drugs Revenue Market Share by Countries (2013-2018)
Figure 2017 Asia Pacific Acute Intermittent Porphyria Drugs Revenue Market Share by Countries
Figure China Acute Intermittent Porphyria Drugs Sales Growth Rate (2013-2018) (K Units)
Figure China Acute Intermittent Porphyria Drugs Revenue Growth Rate (2013-2018) (Million US$)
Figure Japan Acute Intermittent Porphyria Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Japan Acute Intermittent Porphyria Drugs Revenue Growth Rate (2013-2018) (Million US$)
Figure Korea Acute Intermittent Porphyria Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Korea Acute Intermittent Porphyria Drugs Revenue Growth Rate (2013-2018) (Million US$)
Figure India Acute Intermittent Porphyria Drugs Sales Growth Rate (2013-2018) (K Units)
Figure India Acute Intermittent Porphyria Drugs Revenue Growth Rate (2013-2018) (Million US$)
Figure Australia Acute Intermittent Porphyria Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Australia Acute Intermittent Porphyria Drugs Revenue Growth Rate (2013-2018) (Million US$)
Figure Indonesia Acute Intermittent Porphyria Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Indonesia Acute Intermittent Porphyria Drugs Revenue Growth Rate (2013-2018) (Million US$)
Figure Malaysia Acute Intermittent Porphyria Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Malaysia Acute Intermittent Porphyria Drugs Revenue Growth Rate (2013-2018) (Million US$)
Figure Philippines Acute Intermittent Porphyria Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Philippines Acute Intermittent Porphyria Drugs Revenue Growth Rate (2013-2018) (Million US$)
Figure Thailand Acute Intermittent Porphyria Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Thailand Acute Intermittent Porphyria Drugs Revenue Growth Rate (2013-2018) (Million US$)
Figure Vietnam Acute Intermittent Porphyria Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Vietnam Acute Intermittent Porphyria Drugs Revenue Growth Rate (2013-2018) (Million US$)
Figure Central & South America Acute Intermittent Porphyria Drugs Sales Growth Rate 2013-2018 (K Units)
Figure Central & South America Acute Intermittent Porphyria Drugs Revenue Growth Rate 2013-2018 (Million US$)
Table Central & South America Acute Intermittent Porphyria Drugs Sales by Company (2013-2018) (K Units)
Table Central & South America Acute Intermittent Porphyria Drugs Sales Market Share by Company (2013-2018)
Figure Central & South America Acute Intermittent Porphyria Drugs Sales Market Share by Company in 2018
Table Central & South America Acute Intermittent Porphyria Drugs Sales by Type (2013-2018) (K Units)
Table Central & South America Acute Intermittent Porphyria Drugs Sales Market Share by Type (2013-2018)
Figure Central & South America Acute Intermittent Porphyria Drugs Market Share by Type in 2018
Table Central & South America Acute Intermittent Porphyria Drugs Sales by Application (2013-2018) (K Units)
Table Central & South America Acute Intermittent Porphyria Drugs Sales Market Share by Application (2013-2018)
Figure Central & South America Acute Intermittent Porphyria Drugs Market Share by Application in 2018
Table Central & South America Acute Intermittent Porphyria Drugs Sales by Countries (2013-2018) (K Units)
Table Central & South America Acute Intermittent Porphyria Drugs Sales Market Share by Countries (2013-2018)
Figure Central & South America Acute Intermittent Porphyria Drugs Sales Market Share by Countries in 2018
Table Central & South America Acute Intermittent Porphyria Drugs Revenue by Countries (2013-2018) (Million US$)
Table Central & South America Acute Intermittent Porphyria Drugs Revenue Market Share by Countries (2013-2018)
Figure Central & South America Acute Intermittent Porphyria Drugs Revenue Market Share by Countries in 2018
Figure Brazil Acute Intermittent Porphyria Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Brazil Acute Intermittent Porphyria Drugs Revenue Growth Rate (2013-2018) (K Units)
Figure Middle East and Africa Acute Intermittent Porphyria Drugs Sales Growth Rate 2013-2018 (K Units)
Figure Middle East and Africa Acute Intermittent Porphyria Drugs Revenue Growth Rate 2013-2018 (Million US$)
Table Middle East and Africa Acute Intermittent Porphyria Drugs Sales by Type (2013-2018) (K Units)
Table Middle East and Africa Acute Intermittent Porphyria Drugs Sales Market Share by Type (2013-2018)
Figure 2017 Middle East and Africa Acute Intermittent Porphyria Drugs Market Share by Type
Table Middle East and Africa Acute Intermittent Porphyria Drugs Sales by Application (2013-2018) (K Units)
Table Middle East and Africa Acute Intermittent Porphyria Drugs Sales Market Share by Application (2013-2018)
Figure 2017 Middle East and Africa Acute Intermittent Porphyria Drugs Market Share by Application
Table Middle East and Africa Acute Intermittent Porphyria Drugs Sales by Countries (2013-2018) (K Units)
Table Middle East and Africa Acute Intermittent Porphyria Drugs Sales Market Share by Countries (2013-2018)
Figure 2017 Middle East and Africa Acute Intermittent Porphyria Drugs Sales Market Share by Countries
Table Middle East and Africa Acute Intermittent Porphyria Drugs Revenue by Countries (2013-2018) (Million US$)
Table Middle East and Africa Acute Intermittent Porphyria Drugs Revenue Market Share by Countries (2013-2018)
Figure 2017 Middle East and Africa Acute Intermittent Porphyria Drugs Revenue Market Share by Countries
Figure GCC Countries Acute Intermittent Porphyria Drugs Sales Growth Rate (2013-2018) (K Units)
Figure GCC Countries Acute Intermittent Porphyria Drugs Revenue Growth Rate (2013-2018) (K Units)
Figure Egypt Acute Intermittent Porphyria Drugs Sales Growth Rate (2013-2018) (K Units)
Figure Egypt Acute Intermittent Porphyria Drugs Revenue Growth Rate (2013-2018) (K Units)
Figure South Africa Acute Intermittent Porphyria Drugs Sales Growth Rate (2013-2018) (K Units)
Figure South Africa Acute Intermittent Porphyria Drugs Revenue Growth Rate (2013-2018) (K Units)
Table Abbott Company Details
Table Abbott Description and Business Overview
Table Abbott Acute Intermittent Porphyria Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Abbott Acute Intermittent Porphyria Drugs Sales Growth Rate (2013-2018)
Table Abbott Acute Intermittent Porphyria Drugs Sales Market Share in Global Market
Table Abbott Recent Development
Figure Acute Intermittent Porphyria Drugs Value Chain
Table Acute Intermittent Porphyria Drugs Distributors List
Table Acute Intermittent Porphyria Drugs Customers List
Table Global Acute Intermittent Porphyria Drugs Sales Forecast 2018-2025 (K Units) & (Million US$)
Figure Global Acute Intermittent Porphyria Drugs Sales Forecast 2018-2025 (K Units)
Figure Global Acute Intermittent Porphyria Drugs Revenue Forecast 2018-2025 (Million US$)
Table Global Acute Intermittent Porphyria Drugs Sales Forecast by Type 2018-2025 (K Units)
Figure Global Acute Intermittent Porphyria Drugs Sales Forecast by Type 2018-2025 (K Units)
Figure Global Acute Intermittent Porphyria Drugs Sales Market Share Forecast by Type 2018-2025
Table Global Acute Intermittent Porphyria Drugs Sales Forecast by Application 2018-2025 (K Units)
Figure Global Acute Intermittent Porphyria Drugs Sales Forecast by Application 2018-2025 (K Units)
Figure Global Acute Intermittent Porphyria Drugs Sales Market Share Forecast by Application 2018-2025
Table Global Acute Intermittent Porphyria Drugs Sales Forecast by Regions 2018-2025 (K Units)
Figure Global Acute Intermittent Porphyria Drugs Sales Forecast by Regions 2018-2025 (K Units)
Figure Global Acute Intermittent Porphyria Drugs Sales Market Share Forecast by Regions 2018-2025
Table Global Acute Intermittent Porphyria Drugs Revenue Forecast by Regions 2018-2025 (Million US$)
Figure Global Acute Intermittent Porphyria Drugs Revenue Forecast by Regions 2018-2025 (Million US$)
Figure Global Acute Intermittent Porphyria Drugs Revenue Market Share Forecast by Regions 2018-2025
Table North America Acute Intermittent Porphyria Drugs Sales Forecast by Countries 2018-2025 (K Units)
Table North America Acute Intermittent Porphyria Drugs Sales Market Share Forecast by Countries 2018-2025
Table North America Acute Intermittent Porphyria Drugs Revenue Forecast by Countries 2018-2025 (Million US$)
Table North America Acute Intermittent Porphyria Drugs Revenue Market Share Forecast by Countries 2018-2025
Figure United States Acute Intermittent Porphyria Drugs Sales Forecast 2018-2025 (K Units)
Figure Canada Acute Intermittent Porphyria Drugs Sales Forecast 2018-2025 (K Units)
Figure MexicoAcute Intermittent Porphyria Drugs Sales Forecast 2018-2025 (K Units)
Table Europe Acute Intermittent Porphyria Drugs Sales Forecast by Countries 2018-2025 (K Units)
Table Europe Acute Intermittent Porphyria Drugs Sales Market Share Forecast by Countries 2018-2025
Table Europe Acute Intermittent Porphyria Drugs Revenue Forecast by Countries 2018-2025 (Million US$)
Table Europe Acute Intermittent Porphyria Drugs Revenue Market Share Forecast by Countries 2018-2025
Figure Germany Acute Intermittent Porphyria Drugs Sales Forecast 2018-2025 (K Units)
Figure France Acute Intermittent Porphyria Drugs Sales Forecast 2018-2025 (K Units)
Figure UK Acute Intermittent Porphyria Drugs Sales Forecast 2018-2025 (K Units)
Figure Italy Acute Intermittent Porphyria Drugs Sales Forecast 2018-2025 (K Units)
Figure Russia Acute Intermittent Porphyria Drugs Sales Forecast 2018-2025 (K Units)
Table Asia Pacific Acute Intermittent Porphyria Drugs Sales Forecast by Countries 2018-2025 (K Units)
Table Asia Pacific Acute Intermittent Porphyria Drugs Sales Market Share Forecast by Countries 2018-2025
Table Asia Pacific Acute Intermittent Porphyria Drugs Revenue Forecast by Countries 2018-2025 (Million US$)
Table Asia Pacific Acute Intermittent Porphyria Drugs Revenue Market Share Forecast by Countries 2018-2025
Figure China Acute Intermittent Porphyria Drugs Sales Forecast 2018-2025 (K Units)
Figure Japan Acute Intermittent Porphyria Drugs Sales Forecast 2018-2025 (K Units)
Figure Korea Acute Intermittent Porphyria Drugs Sales Forecast 2018-2025 (K Units)
Figure India Acute Intermittent Porphyria Drugs Sales Forecast 2018-2025 (K Units)
Figure Australia Acute Intermittent Porphyria Drugs Sales Forecast 2018-2025 (K Units)
Figure Indonesia Acute Intermittent Porphyria Drugs Sales Forecast 2018-2025 (K Units)
Figure Thailand Acute Intermittent Porphyria Drugs Sales Forecast 2018-2025 (K Units)
Figure Malaysia Acute Intermittent Porphyria Drugs Sales Forecast 2018-2025 (K Units)
Figure Philippines Acute Intermittent Porphyria Drugs Sales Forecast 2018-2025 (K Units)
Figure Vietnam Acute Intermittent Porphyria Drugs Sales Forecast 2018-2025 (K Units)
Table Central & South America Acute Intermittent Porphyria Drugs Sales Forecast by Countries 2018-2025 (K Units)
Table Central & South America Acute Intermittent Porphyria Drugs Sales Market Share Forecast by Countries 2018-2025
Table Central & South America Acute Intermittent Porphyria Drugs Revenue Forecast by Countries 2018-2025 (Million US$)
Table Central & South America Acute Intermittent Porphyria Drugs Revenue Market Share Forecast by Countries 2018-2025
Figure Brazil Acute Intermittent Porphyria Drugs Sales Forecast 2018-2025 (K Units)
Table Middle East and Africa Acute Intermittent Porphyria Drugs Sales Forecast by Regions 2018-2025 (K Units)
Table Middle East and Africa Acute Intermittent Porphyria Drugs Sales Market Share Forecast by Regions 2018-2025
Table Middle East and Africa Acute Intermittent Porphyria Drugs Revenue Forecast by Regions 2018-2025 (Million US$)
Table Middle East and Africa Acute Intermittent Porphyria Drugs Revenue Market Share Forecast by Regions 2018-2025
Figure GCC Countries Acute Intermittent Porphyria Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Egypt Acute Intermittent Porphyria Drugs Sales Growth Rate (2016-2025) (K Units)
Figure South Africa Acute Intermittent Porphyria Drugs Sales Growth Rate (2016-2025) (K Units)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Abbott

★調査レポート[急性間欠性ポルフィリン症薬の世界市場動向・分析2018-2025] (コード:QYR8D00084)販売に関する免責事項を必ずご確認ください。
★調査レポート[急性間欠性ポルフィリン症薬の世界市場動向・分析2018-2025]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆